JP2007520565A5 - - Google Patents

Download PDF

Info

Publication number
JP2007520565A5
JP2007520565A5 JP2006552282A JP2006552282A JP2007520565A5 JP 2007520565 A5 JP2007520565 A5 JP 2007520565A5 JP 2006552282 A JP2006552282 A JP 2006552282A JP 2006552282 A JP2006552282 A JP 2006552282A JP 2007520565 A5 JP2007520565 A5 JP 2007520565A5
Authority
JP
Japan
Prior art keywords
animal
human
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006552282A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007520565A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/003636 external-priority patent/WO2005077940A1/en
Publication of JP2007520565A publication Critical patent/JP2007520565A/ja
Publication of JP2007520565A5 publication Critical patent/JP2007520565A5/ja
Pending legal-status Critical Current

Links

JP2006552282A 2004-02-04 2005-02-04 デヒドロフェニラヒスチン及びそれらの類似体、並びにデヒドロフェニラヒスチン及びそれらの類似体の合成 Pending JP2007520565A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54207304P 2004-02-04 2004-02-04
US62426204P 2004-11-01 2004-11-01
PCT/US2005/003636 WO2005077940A1 (en) 2004-02-04 2005-02-04 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof

Publications (2)

Publication Number Publication Date
JP2007520565A JP2007520565A (ja) 2007-07-26
JP2007520565A5 true JP2007520565A5 (de) 2008-04-03

Family

ID=34864489

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006552282A Pending JP2007520565A (ja) 2004-02-04 2005-02-04 デヒドロフェニラヒスチン及びそれらの類似体、並びにデヒドロフェニラヒスチン及びそれらの類似体の合成

Country Status (9)

Country Link
EP (1) EP1711487A1 (de)
JP (1) JP2007520565A (de)
KR (1) KR101228104B1 (de)
AU (1) AU2005212399B2 (de)
BR (1) BRPI0506655A (de)
CA (1) CA2553630A1 (de)
IL (1) IL176932A0 (de)
NZ (1) NZ548659A (de)
WO (1) WO2005077940A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1529044E (pt) 2002-08-02 2008-01-14 Nereus Pharmaceuticals Inc Desidrofenila-histinas e os seus análogos e a síntese de desidrofenila-histinas e os seus análogos
US7919497B2 (en) 2002-08-02 2011-04-05 Nereus Pharmaceuticals, Inc. Analogs of dehydrophenylahistins and their therapeutic use
US7935704B2 (en) 2003-08-01 2011-05-03 Nereus Pharmaceuticals, Inc. Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
EP1926724A1 (de) * 2005-09-21 2008-06-04 Nereus Pharmaceuticals, Inc. Dehydrophenylahistin-analoga und deren therapeutische verwendung
US8129527B2 (en) 2006-11-03 2012-03-06 Nereus Pharmacuticals, Inc. Analogs of dehydrophenylahistins and their therapeutic use
MX2016004441A (es) * 2013-10-11 2016-10-28 Beyondspring Inc Tratamiento del cancer con una combinacion de plinabulina y taxano.
EP3256130A4 (de) * 2015-02-12 2018-08-01 Beyondspring Pharmaceuticals, Inc. Verwendung von plinabulin in kombination mit immuncheckpoint-inhibitoren
KR102623404B1 (ko) 2015-03-06 2024-01-11 비욘드스프링 파마수티컬스, 인코포레이티드. 뇌 종양 치료 방법
EP3265090A4 (de) 2015-03-06 2018-08-01 Beyondspring Pharmaceuticals Inc. Verfahren zur behandlung von krebs im zusammenhang mit einer ras-mutation
EP3334726B1 (de) * 2015-07-13 2022-03-16 Beyondspring Pharmaceuticals, Inc. Pinabulin-zusammensetzungen
MY192703A (en) 2016-02-08 2022-09-02 Beyondspring Pharmaceuticals Inc Compositions containing tucaresol or its analogs
MX2018015100A (es) 2016-06-06 2019-09-04 Beyondspring Pharmaceuticals Inc Composicion y metodo para reducir la neutropenia.
CN114276332B (zh) 2016-08-12 2023-08-18 深圳华大海洋科技有限公司 脱氢苯基阿夕斯丁类化合物的多晶型及其制备纯化方法和应用
JP2020503363A (ja) 2017-01-06 2020-01-30 ビヨンドスプリング ファーマシューティカルズ,インコーポレイテッド チューブリン結合化合物およびその治療的使用
WO2018144764A1 (en) 2017-02-01 2018-08-09 Beyondspring Pharmaceuticals, Inc. Method of reducing neutropenia
EP3595653B1 (de) * 2017-03-13 2023-03-08 Beyondspring Pharmaceuticals, Inc. Zusammensetzungen von plinabulin und verwendung davon
KR20200112881A (ko) 2018-01-24 2020-10-05 비욘드스프링 파마수티컬스, 인코포레이티드. 플리나불린의 투여를 통해 혈소판감소증을 감소시키는 조성물 및 방법
CN108524442B (zh) * 2018-06-05 2022-01-28 深圳海王医药科技研究院有限公司 一种抗肿瘤药物的注射剂及其制备方法
JP2018199726A (ja) * 2018-09-26 2018-12-20 ビヨンドスプリング インコーポレイテッド プリナブリン及びタキサンの組合せがん治療
EP4412613A1 (de) * 2021-10-07 2024-08-14 Beyondspring Pharmaceuticals, Inc. Verfahren zur behandlung von krebs und tumoren

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3318789C2 (de) * 1983-05-24 1987-04-02 Eduard Gerlach GmbH Chemische Fabrik, 4990 Lübbecke Deodorant
GB9402807D0 (en) * 1994-02-14 1994-04-06 Xenova Ltd Pharmaceutical compounds
US6069146A (en) * 1998-03-25 2000-05-30 The Regents Of The University Of California Halimide, a cytotoxic marine natural product, and derivatives thereof
US6358957B1 (en) * 1998-11-12 2002-03-19 Nereus Pharmaceuticals, Inc. Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compounds
WO2001053290A1 (fr) * 2000-01-18 2001-07-26 Nippon Steel Corporation Inhibiteurs de la division cellulaire et procede de production de ces inhibiteurs
US6635649B2 (en) * 2000-05-09 2003-10-21 Che-Ming Teng Piperazinedione compounds
PT1529044E (pt) * 2002-08-02 2008-01-14 Nereus Pharmaceuticals Inc Desidrofenila-histinas e os seus análogos e a síntese de desidrofenila-histinas e os seus análogos

Similar Documents

Publication Publication Date Title
JP2007520565A5 (de)
JP2006503588A5 (de)
JP2006524283A5 (de)
JP2009524695A5 (de)
FR2881652B1 (fr) Forme pharmaceutique orale microparticulaire anti-mesuage
FR2892937B1 (fr) Forme pharmaceutique orale microparticulaire anti-mesusage
JP2003503454A5 (de)
BRPI0714539A2 (pt) "formas farmacêuticas"
JP2010525055A5 (de)
JP2008519810A5 (de)
JP2009504909A5 (de)
JP2008542528A5 (de)
JP2008513426A5 (de)
JP2008517002A5 (de)
JP2006506499A5 (de)
JP2008513427A5 (de)
JP2005524670A5 (de)
JP2006511228A5 (de)
JP2009509934A5 (de)
IL186851A0 (en) Styrylsulfonamides, their manufacture and use as pharmaceutical agents
DE602006018617D1 (de) Pharmazeutische zusammensetzung mit 2,3-dihydro-6-nitroimidazoä2,1-büoxazolderivaten
JP2006505577A5 (de)
JP2007508806A5 (de)
JP2005531640A5 (de)
RU2003110288A (ru) Вещество, обладающее антидепрессивной активностью